Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid versus ozone injections for rotator cuff tendinopathy
IRCT20241211064021N5Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of medical ozonated water in shoulder tendinopathy (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Change in rotator cuff tendon thickness at 3 months, Change in pain intensity at 3 months and 1 more. Started Mar 2025; status: completed.
02
Drugs
medical ozonated water
03
Conditions
shoulder tendinopathy
Beyond the preview
Go deeper on IRCT20241211064021N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241211064021N5.